openPR Logo
Press release

Cystinosis Treatment Market Foresees Skyrocketing Growth in the Coming Years 2018-2026 And The Top Key Players Are Avrobio, Inc., Gilead, Mylan N.V., Novartis AG, and Orizon Pharma

05-22-2019 01:38 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Cystinosis Treatment

Cystinosis Treatment

Cystinosis is a condition characterized by accumulation of the cystine (amino acid) within cells. High amount of cystine damages cells and often forms crystals that can damage tissues and organs. The eyes and kidneys are mainly susceptible to damage; however, the pancreas, muscles, testes, and thyroid can also be affected. Cystinosis is categorized into three different types; nephropathic, non-nephropathic or ocular, and intermediate cystinosis. Nephropathic (infantile) cystinosis is the most severe and common form of cystinosis. Renal Fanconi syndrome and growth failure are usually the first noticeable symptoms of this disorder.

Ask For Sample Copy of This Business Report : https://www.coherentmarketinsights.com/insight/request-sample/1660

Intermediate cystinosis is characterized by symptoms similar to that of nephropathic cystinosis. However, these symptoms are not prominent till age of 8-20 years. Non-nephropathic cystinosis generally affects adults during middle age with eye disorder. Kidney disease does not occur in these individuals. Individuals with non-nephropathic cystinosis develop photophobia due to cystine crystal accumulation in the eyes.

Cystinosis Treatment Market Dynamics

Various government grants to support the diagnosis and treatment of cystinosis is boosting growth of the market. For instance, in 2013, the Cystinosis Research Foundation awarded six grants worth US $1.29 million to Cystinosis researchers for developing better treatments and a cure for the disease. Organizations such as Cystinosis Research Network are responsible to spread awareness regarding disease by celebrating Cystinosis Awareness Day on May 7, every year. Furthermore, product approval by the Food and Drug Administration (FDA) is expected to boost growth of the cystinosis treatment market over the forecast period. In 2013, the FDA approved the delayed-release formulation of cysteamine bitartrate (DR-C) for patients aged 6 years and above, and the label was expanded in 2015 to include children age two years. Cysteamine is a cystine-depleting agents that reduces cystine levels in cells. It has proven to be effective in preventing or delaying renal failure and improving growth of children with Cystinosis.

Cystinosis Treatment Market Competitive Landscape

Key players operating in the cystinosis treatment market include Avrobio, Inc., Gilead, Mylan N.V., Novartis AG, and Orizon Pharma Plc. Companies in the cystinosis treatment market are focusing on new product development to gain major revenue share. For instance, Avrobio Inc. is planing to initiate clinical development of two gene therapy candidates for cystinosis and Gaucher disease by mid-2019.

Request Customization : https://www.coherentmarketinsights.com/insight/request-customization/1660

Cystinosis treatment Market Regional Insights

Regional segmentation of Cystinosis treatment market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the expected to dominate the cystinosis treatment market. According to an article published by Cystinosis Research Network, an estimated 15 new nephropathic cystinosis cases are diagnosed in the U.S. annually. Moreover, the network also works on increasing awareness about disease among regional population. High prevalence rate of cystinosis in Europe is expected to drive growth of the cystinosis treatment market in the region. According to National Institutes of Health (NIH), cystinosis affects 1 in 26,000 persons in France.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cystinosis Treatment Market Foresees Skyrocketing Growth in the Coming Years 2018-2026 And The Top Key Players Are Avrobio, Inc., Gilead, Mylan N.V., Novartis AG, and Orizon Pharma here

News-ID: 1749230 • Views: 522

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Cystinosis

Cystinosis Treatment Market Analysis, Competitive Assessment and Forecasts to 20 …
The latest Cystinosis Treatment Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thoroughanalysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Cystinosis Treatment Market. Cystinosis
Cystinosis Treatment Market 2021: Market Landscape, Market Sizing and Forecast u …
Cystinosis Treatment Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2021 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the Cystinosis Treatment market growth. Cystinosis or Nephropathic cystinosis is a kind
Cystinosis Treatment Market - Global Industry Insights, Trends, 2026
Cystinosis is a condition characterized by accumulation of the cystine (amino acid) within cells. High amount of cystine damages cells and often forms crystals that can damage tissues and organs. The eyes and kidneys are mainly susceptible to damage; however, the pancreas, muscles, testes, and thyroid can also be affected. Cystinosis is categorized into three different types; nephropathic, non-nephropathic or ocular, and intermediate cystinosis. Nephropathic (infantile) cystinosis is the most
Nephropathic Cystinosis Treatment Market– Growth Opportunities & Technology De …
The report " Nephropathic Cystinosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025", has been prepared based on an in-depth market analysis with inputs from industry experts. The main objective of this report is to define, describe, and forecast the global “Nephropathic Cystinosis Treatment” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an
Cystinosis Disease Therapeutics Market: Regional Markets, Technology, Types, and …
Cystinosis is a rare disease and characterized by accumulation of cystine (a building block of proteins) inside cells. Increase in cystine damages cells and frequently forms crystals that can develop and cause issues in numerous organs and tissues. The kidneys and eyes are particularly defenseless to the damage. Muscles, thyroid, pancreas, and testicles could also be affected. Nephropathic cystinosis, intermediate cystinosis, and non-nephropathic cystinosis are the three types of cystinosis.
Nephropathic Cystinosis Treatment Market Estimated to Flourish by 2025
Nephropathic cystinosis is the leading lysosomal storage disorder caused due to malfunctioning lysosomal membrane transfusion, and it assists as a prototype for a small group of lysosomal transportation disorders. The disease leads to intracellular growth of cysteine in all tissues and organs. Nephropathic cystinosis is an uncommon autosomal recessive disorder with lysosomal storing of the amino acid cysteine due to a deficiency in the membrane transfusion protein, cystinosis. Meanwhile the